
Regulators urge users to seek STI testing after discovering counterfeit products lacking EU safety certifications.
AI-generated summary
The alert follows a rise in STI cases across Europe, with gonorrhea rates reaching record highs in 2023. European authorities are intensifying efforts to curb the circulation of counterfeit medical products.
French health authorities warned Friday that more than 40,000 noncompliant condoms have been sold online in recent months, urging anyone who used affected products to get tested for sexually transmitted infections.
The products were “likely to pose serious risks to the health and safety of users,” including unwanted pregnancies and STIs, France’s consumer-fraud watchdog, the DGCCRF, and its general directorate for health, or DGS, warned Friday. Platforms selling the items were told to “immediately remove the ads,” with 36 listings taken down. Several sites have since promised to review their screening process.
According to the statement, investigators uncovered around 30 condom lines that lacked the EU’s required CE safety marking and third-party conformity checks. Most were sold by Asian vendors through major online marketplaces.
But the problem didn’t stop online.
Tests of CE-marked condoms sold through shops and pharmacies found two faulty products — one carrying a “risk of bursting,” another with “the presence of perforations.” Recalls launched in May and August covered around 260,000 units.
France’s warning follows a wider European crackdown: In July this year, the EU’s anti-fraud office traced more than 200,000 counterfeit condoms circulating under the logo of a well-known brand to a common source in China. Products were seized in Spain, Romania and Serbia.
The French alert lands as STIs are surging across Europe.
There were nearly 100,000 confirmed cases of gonorrhea in Europe in 2023, a 31 percent increase compared to 2022 and an increase of more than 300 percent compared to 2014, the European Centre for Disease Prevention and Control reported. It was the highest recorded rate in Europe since the ECDC started its surveillance of STIs in 2009.
AI outlook — possibilities, not facts
Platforms will implement stricter screening for third-party vendors.
Likely · Within months

The DRC's 17th Ebola outbreak has caused over 2,500 deaths, with half occurring in the last 20 days, spreading exponentially across a vast area larger than France, amid weak state presence and lacking health infrastructure in affected regions.

The WHO alerts that the current Ebola outbreak in eastern Congo, caused by the rare Bundibugyo virus with no approved vaccine, is on track to exceed the 2014-2016 West African outbreak in severity, having already claimed over 2,000 lives amid challenges in conflict-affected areas.

The U.K. medicines regulator authorized Eli Lilly's oral GLP-1 drug Foundayo for weight management and type 2 diabetes, marking the first European license for the pill ahead of expected EU decisions next year.

The FDA has approved Moderna's mRNA-based influenza vaccine, mFLUSIVA, for US adults aged 50 and over, marking the first mRNA flu vaccine authorized in the US, leveraging technology from the Covid-19 pandemic.

The WHO called for increased financial and resource support to tackle the expanding Ebola outbreak in the Democratic Republic of Congo, which has recorded 3,802 confirmed cases and 1,707 deaths.

Poland appeals a Brussels court ruling to pay Pfizer €1.3 billion for 64 million unwanted COVID-19 vaccine doses, citing overlooked factual and legal circumstances, and seeks to freeze the order's enforcement.